Altered Signature of Apoptotic Endothelial Cell-Derived Microvesicles Predicts Chronic Heart Failure Phenotypes

References

• Ponikowski P , VoorsAA, AnkerSDet al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. J. Heart Fail.18, 891–975 (2016).
   PubMed Web of Science ®Google Scholar
• Yancy CW , JessupM, BozkurtBet al. 2013 ACCF/AHA Guideline for the Management of Heart Failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. J. Am. Coll. Cardiol.62, e147–e239 (2013).
   PubMed Web of Science ®Google Scholar
• Petutschnigg J , EdelmannF. Heart failure with mid-range ejection fraction and with preserved ejection fraction. Herz43(5), 392–405 (2018).
   PubMed Web of Science ®Google Scholar
• Bartekova M , RadosinskaJ, JelemenskyM, DhallaNS. Role of cytokines and inflammation in heart function during health and disease. Heart Fail. Rev.23(5), 733–758 (2018).
   PubMed Web of Science ®Google Scholar
• Xu M , YanL, XuJ, YangX, JiangT. Predictors and prognosis for incident in-hospital heart failure in patients with preserved ejection fraction after first acute myocardial infarction: an observational study. Medicine97, e11093 (2018).
   PubMed Web of Science ®Google Scholar
• Voors AA , OuwerkerkW, ZannadFet al. Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure. Eur. J. Heart Fail.19, 627–634 (2017).
   PubMed Web of Science ®Google Scholar
• Curl CL , DanesVR, BellJRet al. Cardiomyocyte functional etiology in heart failure with preserved ejection fraction is distinctive-a new preclinical model. J. Am. Heart Assoc.11, 7 (2018).
   Google Scholar
• Vanderlaan RD , CaldaroneCA, BackxPH. Heart failure in congenital heart disease: the role of genes and hemodynamics. Pflugers Arch.466, 1025–1035 (2014).
   PubMed Web of Science ®Google Scholar
• Berezin AE . Endothelial derived micro particles: biomarkers for heart failure diagnosis and management. J. Clin. Trial Cardiol.2, 1–3 (2015).
   Google Scholar
• Berezin AE , KremzerAA. Impaired phenotype of circulating endothelial microparticles in chronic heart failure patients: relevance to body mass index. Diabetes Metab. Syndr.9, 230–236 (2015).
   PubMed Web of Science ®Google Scholar
• Berezin AE . Endothelial progenitor cells dysfunction and impaired tissue reparation: the missed link in diabetes mellitus development. Diabetes Metab. Syndr.11, 215–220 (2017).
   PubMed Web of Science ®Google Scholar
• Tsukada S , MasudaH, JungSYet al. Impaired development and dysfunction of endothelial progenitor cells in Type 2 diabetic mice. Diabetes Metab.43, 154–162 (2017).
   PubMed Web of Science ®Google Scholar
• Chong AY , BlannAD, PatelJ, FreestoneB, HughesE, LipGY. Endothelial dysfunction and damage in congestive heart failure: relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide. Circulation110, 1794–1798 (2004).
   PubMed Web of Science ®Google Scholar
• Berezin A , ZulliA, KerriganS, PetrovicD, KruzliakP. Predictive role of circulating endothelial-derived microparticles in cardiovascular diseases. Clin. Biochem.48, 562–568 (2015).
   PubMed Web of Science ®Google Scholar
• Berezin AE , KremzerAA, SamuraTA, BerezinaTA, KruzliakP. Impaired immune phenotype of circulating endothelial-derived microparticles in patients with metabolic syndrome and diabetes mellitus. J. Endocrinol. Invest.38, 865–874 (2015).
   PubMed Web of Science ®Google Scholar
• Zhang Z , YangJ, YanW, LiY, ShenZ, AsaharaT. Pretreatment of cardiac stem cells with exosomes derived from mesenchymal stem cells enhances myocardial repair. J. Am. Heart Assoc.1, 5 (2016).
   Google Scholar
• Eming SA , MartinP, Tomic-CanicM. Wound repair and regeneration: mechanisms, signaling, and translation. Sci. Transl. Med.6, 265265sr6 (2014).
   PubMed Web of Science ®Google Scholar
• Berezin AE . Microparticles in chronic heart failure. Adv. Clin. Chem.81, 1–41 (2017).
   PubMed Web of Science ®Google Scholar
• Chow SL , MaiselAS, AnandIet al. American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology; Council on Basic Cardiovascular Sciences; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; Council on Epidemiology and Prevention; Council on Functional Genomics and Translational Biology; and Council on Quality of Care and Outcomes Research. Role of biomarkers for the prevention, assessment, and management of heart failure: a scientific statement from the American Heart Association. Circulation135, e1054–91 (2017).
   PubMed Web of Science ®Google Scholar
• Executive summary: standards of medical care in diabetes – 2013. Diabetes Care36, S4–S10 (2013).
   PubMed Web of Science ®Google Scholar
• National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation106, 3143–3421 (2002).
   PubMed Web of Science ®Google Scholar
• World Health Organization . Waist circumference and waist-hip ratio report of a WHO expert consultation. Geneva, Switzerland (2008).
   Google Scholar
• Ashwell M , GunnP, GibsonS. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes. Rev.13, 275–286 (2012).
   PubMed Web of Science ®Google Scholar
• Lindson-Hawley N , BeghR, McDermottMSet al. The importance of practitioner smoking status: a survey of NHS Stop Smoking Service practitioners. Patient Educ. Couns.93, 139–145 (2013).
   PubMed Web of Science ®Google Scholar
• Quiñones MA , DouglasPS, FosterEet al. American College of Cardiology; American Heart Association; American College of Physicians; American Society of Internal Medicine Task Force on Clinical Competence. American College of Cardiology/American Heart Association clinical competence statement on echocardiography: a report of the American College of Cardiology/American Heart Association/American College of Physicians – American Society of Internal Medicine Task Force on Clinical Competence. Circulation107, 1068–89 (2003).
   PubMed Web of Science ®Google Scholar
• Levey AS , StevensLA, SchmidCHet al. for the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann. Intern. Med.150, 604–612 (2009).
   PubMed Web of Science ®Google Scholar
• Berezin AE , KremnzerAA, BerezinaTA, MartovitskayaYuV. The signature of circulating microparticles in heart failure patients with metabolic syndrome. J. Circ. Biomark.5, 1–10 (2016).
   PubMedGoogle Scholar
• Orozco AF , LewisDE. Flow cytometric analysis of circulating microparticles in plasma. Cytometry77, 502–514 (2010).
   PubMedGoogle Scholar
• Lacroix R , JudiconeC, MooberryMet al. The ISTH SSC Workshop. Standardization of pre-analytical variables in plasma microparticle determination: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop. J. Thromb. Haemost.11, 1190–1193 (2013).
   Web of Science ®Google Scholar
• Chiva-Blanch G , LaakeK, MyhrePet al. Platelet-, monocyte-derived and tissue factor-carrying circulating microparticles are related to acute myocardial infarction severity. PLoS ONE12, e0172558 (2017).
   PubMedGoogle Scholar
• Gohar A , de KleijnDPV, HoesAWet al. Vascular extracellular vesicles in comorbidities of heart failure with preserved ejection fraction in men and women: the hidden players. A mini review. Vascul. Pharmacol.111, 1–6 (2018) [ Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Huang PH , HuangSS, ChenYHet al. Increased circulating CD31+/annexin V+ apoptotic microparticles and decreased circulating endothelial progenitor cell levels in hypertensive patients with microalbuminuria. J. Hypertens.28, 1655–1665 (2010).
   PubMed Web of Science ®Google Scholar
• Werner N , WassmannS, AhlersPet al. Circulating CD31+/annexin V+ apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease. Arterioscler. Thromb. Vasc. Biol.26, 112–116 (2006).
   PubMed Web of Science ®Google Scholar
• McClane N , JeskeW, WalengaJMet al. Identification of novel hemostatic biomarkers of adverse clinical events in patients implanted with a continuous-flow left ventricular assist device. Clin. Appl. Thromb. Hemost.24, 965–972 (2018).
   PubMed Web of Science ®Google Scholar
• Chiva-Blanch GBV , RitschelV, AndersenGØet al. Monocyte-derived circulating microparticles (CD14+, CD14+/CD11b+ and CD14+/CD142+) are related to long-term prognosis for cardiovascular mortality in STEMI patients. Int. J. Cardiol.227, 876–881 (2017).
   PubMed Web of Science ®Google Scholar
• Berezin AE , KremzerAA, SamuraTAet al. Predictive value of apoptotic microparticles to mononuclear progenitor cells ratio in advanced chronic heart failure patients. J. Cardiol.65, 403–411 (2015).
   PubMed Web of Science ®Google Scholar
• Sinning JM , LoschJ, WalentaKet al. Circulating CD31+/annexin V+ microparticles correlate with cardiovascular outcomes. Eur. Heart J.32(16), 2034–2041 (2011).
   PubMed Web of Science ®Google Scholar
• Berezin AE . Impaired phenotype of circulating endothelial-derived microparticles: novel marker of cardiovascular risk. J. Cardiol. Ther.2, 273–278 (2015)
   Google Scholar
• Thulin Å , ChristerssonC, AlfredssonJ, SiegbahnA. Circulating cell-derived microparticles as biomarkers in cardiovascular disease. Biomark. Med.10, 1009–1022 (2016).
   PubMed Web of Science ®Google Scholar
• Cui Y , QiX, HuangAet al. Differential and predictive value of galectin-3 and soluble suppression of tumorigenicity-2 (sST2) in heart failure with preserved ejection fraction. Med. Sci. Monit.24, 5139–5146 (2018).
   PubMed Web of Science ®Google Scholar